BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26182843)

  • 1. Screening for schizophrenia in initial prodromal phase: Detecting the sub-threshold psychosis.
    Razali SM; Abidin ZZ; Othman Z; Yassin MA
    Asian J Psychiatr; 2015 Aug; 16():26-31. PubMed ID: 26182843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of mental states at risk of psychotic transition: validation of the French version of the CAARMS].
    Krebs MO; Magaud E; Willard D; Elkhazen C; Chauchot F; Gut A; Morvan Y; Bourdel MC; Kazes M
    Encephale; 2014 Dec; 40(6):447-56. PubMed ID: 25127895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis.
    Mossaheb N; Becker J; Schaefer MR; Klier CM; Schloegelhofer M; Papageorgiou K; Amminger GP
    Schizophr Res; 2012 Nov; 141(2-3):210-4. PubMed ID: 22986044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early detection of psychotic disorders].
    Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
    Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls.
    Velthorst E; Derks EM; Schothorst P; Becker H; Durston S; Ziermans T; Nieman DH; de Haan L
    Psychiatry Res; 2013 Dec; 210(2):432-7. PubMed ID: 23938166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population screening in Asia: A unique opportunity to enhance early detection of psychosis?
    Woodberry KA
    Asian J Psychiatr; 2015 Dec; 18():97-8. PubMed ID: 26498721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The detection of people with an ultra-high risk of developing psychosis: detection methods and baseline characteristics of the population].
    Rietdijk J; van der Gaag M
    Tijdschr Psychiatr; 2014; 56(4):257-65. PubMed ID: 24807385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental socioeconomic status and prognosis in individuals with ultra-high risk for psychosis: A 2-year follow-up study.
    Hur JW; Choi SH; Yun JY; Chon MW; Kwon JS
    Schizophr Res; 2015 Oct; 168(1-2):56-61. PubMed ID: 26213342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosis-like experiences and distress among adolescents using mental health services.
    Kline E; Thompson E; Bussell K; Pitts SC; Reeves G; Schiffman J
    Schizophr Res; 2014 Feb; 152(2-3):498-502. PubMed ID: 24411529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosis risk screening in youth: a validation study of three self-report measures of attenuated psychosis symptoms.
    Kline E; Wilson C; Ereshefsky S; Denenny D; Thompson E; Pitts SC; Bussell K; Reeves G; Schiffman J
    Schizophr Res; 2012 Oct; 141(1):72-7. PubMed ID: 22921375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
    Ruhrmann S; Schultze-Lutter F; Salokangas RK; Heinimaa M; Linszen D; Dingemans P; Birchwood M; Patterson P; Juckel G; Heinz A; Morrison A; Lewis S; von Reventlow HG; Klosterkötter J
    Arch Gen Psychiatry; 2010 Mar; 67(3):241-51. PubMed ID: 20194824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Movement disorders as a prodromal sign in individuals at high risk of psychosis].
    van Harten PN; Bakker PR; van Os J
    Tijdschr Psychiatr; 2015; 57(2):77-82. PubMed ID: 25669942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal validation of psychosis risk screening tools.
    Kline E; Thompson E; Demro C; Bussell K; Reeves G; Schiffman J
    Schizophr Res; 2015 Jul; 165(2-3):116-22. PubMed ID: 25975827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.